Cargando…

Exploring the cost-effectiveness of high versus low perioperative fraction of inspired oxygen in the prevention of surgical site infections among abdominal surgery patients in three low- and middle-income countries

BACKGROUND: This study assessed the potential cost-effectiveness of high (80–100%) vs low (21–35%) fraction of inspired oxygen (FiO(2)) at preventing surgical site infections (SSIs) after abdominal surgery in Nigeria, India, and South Africa. METHODS: Decision-analytic models were constructed using...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457493/
https://www.ncbi.nlm.nih.gov/pubmed/37655933
http://dx.doi.org/10.1016/j.bjao.2023.100207
Descripción
Sumario:BACKGROUND: This study assessed the potential cost-effectiveness of high (80–100%) vs low (21–35%) fraction of inspired oxygen (FiO(2)) at preventing surgical site infections (SSIs) after abdominal surgery in Nigeria, India, and South Africa. METHODS: Decision-analytic models were constructed using best available evidence sourced from unbundled data of an ongoing pilot trial assessing the effectiveness of high FiO(2), published literature, and a cost survey in Nigeria, India, and South Africa. Effectiveness was measured as percentage of SSIs at 30 days after surgery, a healthcare perspective was adopted, and costs were reported in US dollars ($). RESULTS: High FiO(2) may be cost-effective (cheaper and effective). In Nigeria, the average cost for high FiO(2) was $216 compared with $222 for low FiO(2) leading to a −$6 (95% confidence interval [CI]: −$13 to −$1) difference in costs. In India, the average cost for high FiO(2) was $184 compared with $195 for low FiO(2) leading to a −$11 (95% CI: −$15 to −$6) difference in costs. In South Africa, the average cost for high FiO(2) was $1164 compared with $1257 for low FiO(2) leading to a −$93 (95% CI: −$132 to −$65) difference in costs. The high FiO(2) arm had few SSIs, 7.33% compared with 8.38% for low FiO(2,) leading to a −1.05 (95% CI: −1.14 to −0.90) percentage point reduction in SSIs. CONCLUSION: High FiO(2) could be cost-effective at preventing SSIs in the three countries but further data from large clinical trials are required to confirm this.